Novavax’s Uphill Battle to Vaccine Success

Novavax’s Uphill Battle to Vaccine Success

Source: 
BioSpace
snippet: 

A week ago, Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of NVX-CoV2373, its COVID-19 vaccine candidate, for the COVAX Facility. The vaccine will be manufactured and distributed around the world by Novavax and Serum Institute of India (SII). SII has an existing deal with Gavi.